These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9342545)

  • 1. Improved metabolic control preserved beta-cell function two years after diagnosis of insulin-dependent diabetes mellitus.
    Montanya E; Fernandez-Castañer M; Soler J
    Diabetes Metab; 1997 Sep; 23(4):314-9. PubMed ID: 9342545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of clinical presentation and metabolic control of insulin dependent diabetes in the evolution of residual insulin secretion. A prospective study at five years].
    Fernández Castañer M; Gonzálbez J; Carrera MJ; Nacher V; Montanya E; Abós R; Soler J
    Med Clin (Barc); 1997 Sep; 109(9):328-32. PubMed ID: 9379763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA).
    Zhou Z; Li X; Huang G; Peng J; Yang L; Yan X; Wang J
    Diabetes Metab Res Rev; 2005; 21(2):203-8. PubMed ID: 15386806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
    Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
    Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of sex hormones and sex hormone binding globulin in male patients with insulin dependent diabetes mellitus. Effect of improved blood glucose regulation.
    Christensen L; Hagen C; Henriksen JE; Haug E
    Dan Med Bull; 1997 Nov; 44(5):547-50. PubMed ID: 9408741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years.
    Nordwall M; Ludvigsson J
    Diabetes Metab Res Rev; 2008 Sep; 24(6):472-9. PubMed ID: 18613248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S
    Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medication use in diabetes mellitus (VI). Economics and effectiveness of insulin and sulfonyl-urea combination therapy compared with conventional two daily doses].
    Costa B; Estopá A; Borrás J; Sabaté A
    Med Clin (Barc); 1998 Nov; 111(15):568-72. PubMed ID: 9859089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes.
    Vantyghem MC; Marcelli-Tourvieille S; Fermon C; Duhamel A; Raverdy V; Arnalsteen L; Kerr-Conte J; Noel C; Fontaine P; Pattou F
    Transplantation; 2009 Jan; 87(1):66-71. PubMed ID: 19136893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of mealtime insulin lispro in comparison to glibenclamide in early type 2 diabetes.
    Forst T; Eriksson JW; Strotmann HJ; Bai S; Brunelle R; Gulliya KS; Gack S; Gudat U
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):97-103. PubMed ID: 12746761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70.
    Schernthaner G; Kopp HP; Ristic S; Muzyka B; Peter L; Mitteregger G
    Horm Metab Res; 2004 Mar; 36(3):188-93. PubMed ID: 15057674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue.
    Uçkaya G; Delagrange P; Chavanieu A; Grassy G; Berthault MF; Ktorza A; Cerasi E; Leibowitz G; Kaiser N
    J Endocrinol; 2005 Mar; 184(3):505-13. PubMed ID: 15749809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study.
    Wallace TM; Levy JC; Matthews DR
    Diabet Med; 2004 Jun; 21(6):568-76. PubMed ID: 15154941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual beta-cell function in children with type 1 diabetes: measurement and impact on glycemic control.
    Daneman D; Clarson C
    Clin Invest Med; 1987 Sep; 10(5):484-7. PubMed ID: 3315370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
    Crinó A; Schiaffini R; Ciampalini P; Suraci MC; Manfrini S; Visalli N; Matteoli MC; Patera P; Buzzetti R; Guglielmi C; Spera S; Costanza F; Fioriti E; Pitocco D; Pozzilli P;
    J Pediatr Endocrinol Metab; 2005 Aug; 18(8):749-54. PubMed ID: 16200840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy with insulin and sulfonylurea for the treatment of new-onset insulin-dependent diabetes mellitus.
    Fallucca F; Sciullo E; Maldonato A
    Horm Metab Res; 1996 Feb; 28(2):86-8. PubMed ID: 8867904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years.
    Pozzilli P; Visalli N; Buzzetti R; Baroni MG; Boccuni ML; Fioriti E; Signore A; Mesturino C; Valente L; Cavallo MG
    Diabete Metab; 1995 Feb; 21(1):47-9. PubMed ID: 7781843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.